Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish Familial Mediterranean Fever patients with and without amyloidosis

Amyloid

Volumn 10, Issue 1, 2003, Pages 12-16

  Akar, Nejat ^a,c   Hasipek, Metis ^a   Akar, Ece ^a   Ekim, Mesiha ^a   Yalçinkaya, Fatos ^a   Çakar, Nilgün ^b  

^a ANKARA UNIVERSITY   (Turkey)

^b Social Security Hospital   (Turkey)

^c NONE   (Turkey)

Author keywords

Amyloidosis; Familial Mediterranean fever; Serum Amyloid A; Tumor necrosis factor alpha

Indexed keywords

ADENINE; AMYLOID PRECURSOR PROTEIN; CYTOKINE; GUANINE; SERUM AMYLOID A; SERUM AMYLOID A1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALLELE; AMYLOIDOSIS; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FAMILIAL MEDITERRANEAN FEVER; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; HOMOZYGOSITY; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; TURKEY (REPUBLIC);

EID: 0037367577     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506120308995251     Document Type: Article

References (31)

1. Centola M, Aksentijevich I, and Kastner DL (1998). The hereditary periodic fever syndromes: molecular analysis of a new family of inflammatory diseases. Hum Mol Genet 7, 1581-1588
2. Sohar E, Gafni J, Pras M, and Heller H (1967). Familial Mediterranean fever: a survey of 470 cases and review of the literature. Am J Med 43 227-253
3. Zemer D, Pras M, Sohar E, Modan M, Cabili S, and Gafni J (1986). Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever. N Eng J Med 1001-1005
4. Özer FL, Kaplan E, and Zileli S (1971). Familial Mediterranean Fever in Turkey. Am J Med 53, 336-339
5. Özdemir AI, Sökmen C (1969). Familial Mediterranean Fever among the Turkish people. Am J Gastroenterol 51, 311-316
6. Saatçi Ü, Özen S, Özdemir S, Bakkaglolu A, Besbas N, Topaloglu R, and Arslan S (1997). Familial Mediterranean Fever in children: report of a large series and discussion of prognostic factors of amyloidosis. Eur J Pediatr 156, 619-623
7. Yalçinkaya F, Tümer N, Tekin M, Çakar N, and Akçakus M (1997). Familial Mediterranean Fever in Turkish children (analysis of 110 cases). In: Sohar E, Gafni J, and Pras M (eds). Familial Mediterranean Fever, pp 157-161. (Tel Aviv: Freund Publishing House)
8. The International FMF Consortium (1997). Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90, 797-807
9. The French FMF Consortium (1997). A candidate gene for familial Mediterranean fever. Nature Genet 17, 25-31
10. Touitou I. (2000). The spectrum of FMF Mutations in familial Mediterranean Fever, II. International Conference, Lectures and Abstracts, (3-7 May 2000), Antalya, Turkey, pp:23-26
11. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M and Pras E (1999). MEFV mutations analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid: Int J Exp Clin Invest 6, 1-6
12. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Lotan R, Ogur G, Sirin A, Schlezinger M, Halpern GJ, Schwabe A, Kastner DL, Rotter JI, and Fischel-Ghodsian N (1999). Phenotype- genotype correlations in familial-Mediterranean fever: evidence for an association between Met 694 Val and amyloidosis. Eur J Hum Genet 3, 287-292
13. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, and Amselem S (1999). MEFV-gene analysis in Armenian patients with familial Mediterranean fever. Diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65, 88-97
14. Yalçinkaya F, Akar N, and Misirliogu M (1998). Familial Mediterranean fever- amyloidosis and the Va1726Ala mutations. N. Eng J Med 338, 993-994
15. Akar N, Misirlioglu M, Yalcinkaya F, Akar E, Cakar N, Tumer N, Akcakus M, Tastan H, and Matzner Y (2000). MEFV mutations in Turkish patients suffering from familial Mediterranean fever. Human Mutation 15, 118-119
16. Akar N, Yalçinkaya F, Akar E, and Çakar N (1999). MEFV mutation analysis in Turkish familial Mediterranean fever patients with amyloidosis. Amyloid: Int J Exp Clin Invest 6, 301-302
17. Yalçinkaya F, Çakar N, Misirliogu M, Tümer N, Akar N, Tekin M, Tastan H, Koçak II, Özkaya N, and Elhan AH (2000). Genotype-phenotype correlation in a large group of Turkish patients with familial Mediterranean fever: evidence for mutation independent amyloidosis. Rheumatology 39, 67-72
18. Yamada T, Okuda Y, and Itoh Y (1998). The frequency of serum amyloid A2 alleles in the Japanese population. Amyloid: Int J Exp Clin Invest 5, 208-211
19. Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, Chen C, and Kamatani N (1999). Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA amyloidosis in patients with rheumatoid arthritis. Hum Genet 105, 360-366
20. Editorial (1999). Revised nomenclature for serum amyloid A (SAA). Amyloid: Int J Exp Clin Invest 6, 67-70
21. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tusutsui Y, Shirasawa H (1995). A novel allelic variant of serum amyloid A, SAA1γ genomic evidence, evolution, frequency and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 4, 1083-1087
22. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, and Kamatani N (2001). A novel single-nucleotide polymorphism at the 5′-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 44, 1266-1272
23. Cazeneuve C, Ajrapetyan H, Papin S, Thoroval FR, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, Duguesnay P, Kouyoumdjian J, Giradan-Boulandet E, Grateau G, Sarkisian T, and Amselem S (2000). Identification of MEFV- Independent modifying genetic factors for Familial Mediterranean fever. Am J Hum Genet 67, 1136-1143
24. Wilson A, Symons J, McDowell T, Mc Dewitt H, and Duff G (1997). Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptinal activation. Proc Natl Acad Sci 94, 3195-3199
25. Touitou I, Picot MC, Domingo C, Notarnicola C, Cattan D, Demaille J, and Kone-Paul I (2001). The MICA region determines the first modifier locus in familial Mediterranean fever. Arthritis Rheum 44, 163-169
26. Livneh A, Langevita P, Zemer D, Zaks N, Kees S, Lidar T, and Pras M (1997). Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40, 1879-1885
27. Akar H, Keven K, Nergizoglu G, Erturk S, Ates K, Erbay B, Akar N, Duman N, and Karatan O (2000). Renal amyloidosis in a patient with homozygous sickle cell anemia and M694V/M694V mutation. Nephron 86, 383-4
28. Brown K, Luddington R, and Baglin T (1998). A common polymorphism in the tumor necrosis factor-alpha gene associated with high TNF levels is not a risk factor for venous thrombo-embolism. Br J Haematol 101,480-482
29. Akar N, Hasipek M (2002). Tumor Necrosis Factor-alpha gene polymorphism (-308 G-A) in Turkish Pediatric Thrombosis Patients. Turk J Haemat 19, 39-41
30. Tekin M, Yalçinkaya F, Çakar N, Akar N, Misirliogu M, Tastan H and Tümer N (2000). MEFV mutations in multiplex families with familial Mediterranean fever: is a particular genotype necessary for amyloidosis? Clin Genet 57, 430-434
31. Amar S, Han X (2002) Regulation of tumour necrosis factor-α gene expression. Applied Genom Proteom 1, 31-44